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abstractOBJECTIVES: An association between maternal smoking during pregnancy and offspring
attention-deﬁcit/hyperactivity disorder (ADHD) has been shown across several studies based
on self-reports. No previous studies have investigated the association of nicotine exposure
measured by cotinine levels during pregnancy and offspring ADHD.
METHODS: In this population-based study, 1079 patients born between 1998 and 1999 and
diagnosed with ADHD according to the International Classiﬁcation of Diseases and 1079
matched controls were identiﬁed from Finnish nationwide registers. Maternal cotinine levels
were measured by using quantitative immunoassays from maternal serum specimens
collected during the ﬁrst and second trimesters of pregnancy and archived in the national
biobank.
RESULTS: There was a signiﬁcant association between increasing log-transformed maternal
cotinine levels and offspring ADHD. The odds ratio was 1.09 (95% conﬁdence interval [CI]
1.06–1.12) when adjusting for maternal socioeconomic status, maternal age, maternal
psychopathology, paternal age, paternal psychopathology, and child’s birth weight for
gestational age. In the categorical analyses with cotinine levels in 3 groups, heavy nicotine
exposure (cotinine level .50 ng/mL) was associated with offspring ADHD, with an odds ratio
of 2.21 (95% CI 1.63–2.99) in the adjusted analyses. Analyses by deciles of cotinine levels
revealed that the adjusted odds for offspring ADHD in the highest decile was 3.34 (95% CI
2.02–5.52).
CONCLUSIONS: The study reveals an association with and a dose-response relationship between
nicotine exposure during pregnancy and offspring ADHD. Future studies incorporating
maternal smoking and environmental, genetic, and epigenetic factors are warranted.
WHAT’S KNOWN ON THIS SUBJECT: Exposure to maternal
smoking is associated with various adverse perinatal
outcomes. Association between maternal smoking and
offspring attention-deﬁcit/hyperactivity disorder has been
shown across studies. However, the causality of the
association has been questioned to be mostly due to
familial confounding.
WHAT THIS STUDY ADDS: In this ﬁrst nationwide study,
objectively measured nicotine exposure through maternal
cotinine levels allows us to overcome underreporting of
smoking during pregnancy. We report a strong
association as well as a dose-dependent relationship
between prenatal nicotine exposure and offspring
attention-deﬁcit/hyperactivity disorder.
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Despite its proven negative effects on
fetal development, smoking during
pregnancy remains a signiﬁcant
public health issue. Approximately
7.2% of women who gave birth in the
United States smoked cigarettes
during pregnancy in 2016.1 The
prevalence rate was similar in
Finland, with ∼7% of all pregnant
women continuing to smoke
throughout their pregnancy.2
Exposure to maternal smoking has
been associated with various adverse
outcomes, such as obstetric
complications, low birth weight,
preterm birth, sudden infant death
syndrome, and increased infections in
childhood.3 An association between
maternal smoking and offspring
attention-deﬁcit/hyperactivity
disorder (ADHD) has been shown
across numerous studies from
different populations.3–7 However, the
causality of the association has been
questioned to be mostly due to
familial confounding.3,8–13 Moreover,
to date, the information on maternal
smoking is typically based solely on
maternal self-report.
In previous studies, maternal self-
report of smoking has been shown to
underestimate true smoking by 8%
to 28%.14–16 Disclosure of smoking
is lower among pregnant smokers
than women who smoke in general.
Cotinine is the most appropriate
biomarker indicating nicotine
exposure because of the short half-life
of nicotine, which is primarily
metabolized to cotinine in the liver.17
Although previous studies are based
on self-reports of active smoking,
cotinine measurements enable
quantifying the amount of nicotine
exposure and detecting nicotine
exposure from other sources, such as
nicotine replacement therapy or
passive smoking. However, authors of
no previous studies have investigated
the association of prenatal cotinine
levels and the risk of offspring ADHD.
In 2 previous studies that have
examined the association between
maternal cotinine levels in pregnancy
and childhood behavioral outcomes
on the basis of parental
questionnaires, the authors reported
no association.18,19
This is the ﬁrst study to investigate
the association between maternal
cotinine levels during pregnancy
and ADHD diagnosis in offspring. In
this population-based case-control
study, the use of objectively
measured nicotine exposure allows
us to overcome underreporting of
smoking. On the basis of ﬁndings
from previous studies revealing an
association between self-reported
maternal smoking during
pregnancy and ADHD diagnosis in
offspring, we hypothesized that
there is an association between
maternal cotinine levels and
offspring ADHD. In addition, our
study allows us to examine possible
dose-response effects between
maternal cotinine levels and
offspring ADHD.
METHODS
The current study is based on the
Finnish prenatal study of ADHD
(Fig 1), a nested case-control study
derived from all singleton live births
in Finland between January 1, 1998,
and December 31, 1999, and
followed-up for any ADHD diagnosis
in the Finnish Hospital Discharge
Register (FHDR) by December
31, 2011.
Finnish Maternity Cohort
All offspring in the Finnish prenatal
study of ADHD were derived from the
Finnish Maternity Cohort (FMC). The
FMC consists of 2 million serum
samples collected during the ﬁrst and
early second trimester of pregnancy
(ﬁfth to 95th percentile: months 2–4
of pregnancy) from .950000 women
since the beginning of 1983. After
informed consent, blood samples
were collected at Finnish maternity
clinics for the purpose of screening
FIGURE 1
Flowchart of the study design. PRC, Population Register Center.
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for congenital infections (HIV,
hepatitis B, and syphilis). One
maternal serum sample was obtained
from each pregnancy. The median
gestational age of serum collection for
subjects in this study was 10 weeks
(interquartile range: 8–12 weeks).
After the screening, ∼1 to 3 mL of
serum from each pregnancy are
stored at 225°C in a protected
biorepository at Biobank Borealis in
Oulu, Finland, and are available for
scientiﬁc research.20 Linkage between
FMC data and the Finnish health
registries and other data sources is
possible by using the Finnish
personal identity code (PIC), which
has been assigned to all residents of
Finland since 1971.21
Nationwide Registers
The Population Information System
was established by the Finnish
Population Register Center in 1969
and subsequently computerized in
1971. It is a computerized national
register containing basic information
about Finnish citizens and foreign
permanent residents. The personal
data in the system include name,
PIC, address, citizenship and native
language, family relations, and date of
birth and death (if applicable). The
Finnish Medical Birth Register
(FMBR), established in 1987, includes
comprehensive and standardized data
on the perinatal period for all live
births and stillbirths of fetuses with
a birth weight of at least 500 g or
a gestational age of at least 22 weeks.
Patients and Controls
The patients with ADHD were
identiﬁed by linking the information
from the FHDR with the FMC using
the PIC. The FHDR contains all
inpatient diagnoses since 1967 and
outpatient diagnoses from specialized
services since 1998. The FHDR
contains the patient’s PIC, hospital
identiﬁcation, and primary and
secondary diagnoses. The diagnostic
classiﬁcation is based on the
International Classiﬁcation of
Diseases; the International
Classiﬁcation of Diseases, 10th
Revision (ICD-10) has been used since
1996.22 From 1987 to 1995 the
diagnoses were coded according to
the International Classiﬁcation of
Diseases, Ninth Revision (ICD-9),23
and from 1969 to 1986 according to
the International Classiﬁcation of
Diseases, Eighth Revision (ICD-8).24
Finland has a system of regular
assessment of children’s physical and
psychological development by well-
trained health professionals. Almost
all children attend free health check-
ups at least 15 times during their ﬁrst
6 years of life followed by annual
check-ups at school. ADHD is typically
diagnosed on the basis of the
assessment of a specialist in
psychiatry or neurology in public
outpatient services free of charge.
A previous study, in which the
authors evaluated the validity of the
ADHD diagnosis in the FHDR,
revealed that 88% of subjects
examined met the Diagnostic and
Statistical Manual of Mental Disorders,
Fourth Edition diagnostic criteria for
ADHD.25
In the current study, the patients with
ADHD included singletons born in
Finland between 1998 and 1999 and
registered in the FHDR with the ICD-
10 code for hyperkinetic disorders
(F90.0) until 2011. Controls were
deﬁned as singleton offspring born in
Finland without a diagnosis of ADHD,
conduct disorder, or severe or
profound intellectual disability in the
FHDR. Each participant with ADHD
was matched with 1 control on date
of birth (630 days), sex, and place of
birth. The controls had to be alive and
living in Finland at the date of the
ADHD diagnosis of the matched
patient. Patients and controls were
selected from these years because of
the lack of earlier availability of data
from the FMBR (established in 1987)
and to ensure greater uniformity of
the serum specimens with regard to
the time of sampling and storage. In
the current study, of the 1320 total
patients and controls identiﬁed,
sufﬁcient serum was available in the
FMC for 1079 patients and matched
controls (n = 1079). The study was
approved by the ethical committees
of the Hospital District of Southwest
Finland and the National Institutes of
Health and Welfare. Informed consent
was obtained before collection of
maternal serum.
Cotinine Measurements
Cotinine measurements from the FMC
samples were conducted blind to
patient/control status. Serum
cotinine levels were measured by
using a commercially available
quantitative immunoassay kit
(OraSure Technologies, Bethlehem,
PA) (sensitivity = 96%–97%;
speciﬁcity = 99%–100%). Intra-assay
and interassay variation are 3.5% to
6.2%, and 6.0% to 9.6%, respectively.
The results are reported in nanogram
per milliliter.
Covariates
The covariates included variables that
have been previously shown to be
associated with both maternal
smoking as well as offspring ADHD:
number of previous births, maternal
socioeconomic status (SES), maternal
psychiatric history, maternal history
of ADHD diagnosis, maternal history
of substance use disorder, paternal
psychiatric history, paternal history of
ADHD diagnosis, gestational age of
the child, birth weight for gestational
age (BWGA; based on national sex-
speciﬁc growth curves26), maternal
age, paternal age, and gestational
week of blood draw. Information on
number of previous births, maternal
SES, maternal age, and gestational age
was obtained from the FMBR.
Maternal and paternal psychiatric
diagnoses were obtained from the
FHDR. A parent was deﬁned as having
a psychiatric history if he or she had
any psychiatric diagnoses registered
in the FHDR during his or her
lifetime (ICD-10 codes F10–F99
[corresponding to ICD-9 codes
291–316 and ICD-8 codes 291–309]),
excluding intellectual disability (ICD-
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10 codes F70–F79) or a diagnosis of
ADHD (ICD-10 code F90.x or ICD-9
code 314.x). For mothers, the
association with disorders due to
alcohol or substance abuse (ICD-10
codes F10–F19; ICD-9 codes 291–292
and 303–305; and ICD-8 codes 291,
303, and 304) was tested separately
from other psychiatric disorders.
Paternal age was obtained from the
Finnish Population Register Center,
and gestational week of blood draw
was obtained from the FMC. The
covariates were considered for
inclusion in the models on the basis
of associations with both cotinine
exposure and ADHD at P # .1, in
accord with standard texts.27
Statistical Analysis
The analysis was based on a nested
case-control design, in which the
controls for each patient were
identiﬁed from the population at risk
and matched on selected factors (see
Patients and Controls). Initially,
cotinine was examined as a continuous
measure. Because of the skewed
distribution of cotinine, the variable
was log-transformed before analysis.
To further facilitate data
interpretation, we examined maternal
cotinine as categorized into deciles
and as a 3-class categorical variable:
reference (,20 ng/mL); moderate
exposure (20–50 ng/mL); and heavy
exposure (.50 ng/mL). The deciles
for the patient and control groups in
the analyses were derived from the
cut points of maternal cotinine levels
that deﬁned the deciles for this
biomarker in the control group. We
hypothesized that a signiﬁcant
association would be observed for
maternal cotinine classiﬁed in the
highest decile compared with the
reference group, which was deﬁned
as the lowest decile. The cutoff points
for the 3-class categorical variable
were based on the manufacturer’s
recommendation and have been used
in previous studies on the basis of the
FMC serum bank.28,29 These levels
also corresponded well with the
frequencies of self-reported maternal
smoking. Among mothers of patients
with ADHS, smoking was reported by
56 of 702 (7.9%) mothers in the
reference category of ,20 ng/mL, by
62 of 80 (77%) mothers with cotinine
levels of 20 to 50 ng/mL, and by 196
of 214 (91.5%) mothers with cotinine
levels .50 ng/mL (P , .001).
Appropriate to the nested case-
control study design, point and
interval estimates of odds ratios
(ORs) were obtained by ﬁtting
conditional logistic regression models
for matched pairs. Statistical
signiﬁcance was based on P , .05. All
the statistical analyses were
performed with SAS software (SAS
9.4; SAS Institute, Inc, Cary, NC).
RESULTS
The mean age of the patients at the
time of the ADHD diagnosis was
7.3 years (SD: 1.9; range: 2–13.7
years). As shown in Supplemental
Table 7, there was no difference in
covariates between 1079 patients
included in the analysis and 241
patients not included because of
insufﬁcient serum, except for paternal
age. The mean paternal age among
patients not included was 1.2 years
(SD: 6.9) older than that of patients
included (P = .02) in the analysis. The
mean cotinine level was 27.4 ng/mL
(SD: 54.8; range: 0.0–427.7 ng/mL)
among patients and 11.3 ng/mL (SD:
34.5; range: 0.0–320.0 ng/mL) among
controls. Supplemental Table 4
reveals the distribution of serum
cotinine levels and corresponding
TABLE 1 Association Between Maternal Serum Cotinine (Log-Transformed and 3-Class Categorical Variables) and Offspring ADHD
Patient Control Association With Maternal Serum Cotinine
OR 95% CI P
Maternal cotinine levels (ng/mL), median 27.4 11.3 — — —
Log-transformed analysis
Unadjusted — — 1.14 1.11–1.17 ,.001
Model 1a — — 1.09 1.06–1.13 ,.001
Model 2b — — 1.10 1.06–1.13 ,.001
Categorical analysis
Unadjusted
Reference, n (%)c 777 (72.0) 936 (86.8) — — —
Moderated 84 (7.8%) 54 (5.0%) 1.92 1.33–2.77 ,.001
Heavy exposuree 218 (20.2%) 89 (8.2%) 2.95 2.25–3.88 ,.001
Model 1a
Moderate exposured — — 1.27 0.84–1.92 .25
Heavy exposuree — — 2.21 1.64–2.99 ,.001
Model 2b
Moderate exposured — — 1.31 0.87–1.96 .20
Heavy exposuree — — 2.27 1.69–3.07 ,.001
—, not applicable.
a Model 1: adjusted for BWGA, maternal SES, maternal age, maternal psychopathology, maternal substance abuse, paternal age, and paternal psychopathology.
b Model 2: adjusted for BWGA, maternal SES, maternal age, maternal psychopathology, maternal substance abuse, and paternal age.
c Reference: ,20 ng/mL.
d Moderate exposure: 20–50 ng/mL.
e Heavy exposure: .50 ng/mL.
4 SOURANDER et al
 by guest on March 15, 2019www.aappublications.org/newsDownloaded from 
self-reported smoking status in the
sample. As shown in the table, the
prevalence of self-reported smoking
status increased with increasing
serum cotinine levels.
As shown in Supplemental Table 5,
maternal SES, psychopathology,
substance abuse, ADHD, age, and
number of previous births; paternal
psychopathology, ADHD, and age;
and the child’s gestational age and
BWGA were associated (P , .1)
with offspring ADHD (see
Supplemental Table 5). As shown in
Supplemental Table 6, maternal SES,
psychopathology, substance use, and
age; paternal psychopathology; and
the child’s BWGA were associated
with maternal serum cotinine levels.
Gestational week of blood draw was
not associated with these outcomes
(see Supplemental Table 6). Maternal
SES, psychopathology, substance use,
and age; paternal psychopathology;
and the child’s BWGA were associated
with both offspring ADHD and
maternal cotinine levels and therefore
fulﬁlled criteria for confounding.
Furthermore, adjustment was made
for paternal age to address any
potential selection bias because of its
difference among included and
missing patients with ADHD.
The main ﬁndings of the current
study are shown in Table 1. The
adjusted analyses were performed by
using 2 models. Model 1 contained
the child’s BWGA, maternal SES,
maternal age, maternal
psychopathology, maternal substance
abuse, paternal age, and paternal
psychopathology as confounders.
Model 2 contained the same
confounders as in model 1 except for
paternal psychopathology to
speciﬁcally assess the effect of
maternal factors. There was
a signiﬁcant association between
increasing log-transformed maternal
cotinine levels and offspring ADHD
both in unadjusted analyses (OR:
1.14; 95% conﬁdence interval [CI]:
1.11–1.17) as well as adjusted
analyses. In model 1, the OR was 1.09
(95% CI: 1.06–1.12), and in model 2,
the OR was 1.10 (95% CI: 1.06–1.13).
In the categorical analyses, cotinine
levels were categorized into 3 groups:
heavy ( .50 ng/mL), moderate
(20–50 ng/mL), and no or low
nicotine exposure (,20 ng/mL). As
shown in Table 1, heavy exposure
was associated with offspring ADHD in
the unadjusted analyses (OR: 2.95; 95%
CI: 2.25–3.88) as well as in the adjusted
analyses both in model 1 (OR: 2.21;
95% CI: 1.63–2.99) and in model 2 (OR:
2.27; 95% CI: 1.68–3.07). Moderate
cotinine levels were associated with
offspring ADHD in the unadjusted
analyses (OR: 1.92; 95% CI: 1.33–2.77)
but did not remain signiﬁcant in the
adjusted models (model 1: OR: 1.27
[95% CI: 0.84–1.92]; model 2: OR: 1.31
[95% CI: 0.87–1.96]).
The distribution of cotinine exposure
in deciles by case-control status is
presented in Table 2. As shown in
Fig 2, the strongest association was in
the highest decile (90%–100%). The
odds for offspring ADHD in the
highest decile in the unadjusted
analyses was 4.90 (95% CI: 3.10–7.76),
whereas in the analyses adjusting for
BWGA, maternal SES, maternal age,
maternal psychopathology, maternal
substance abuse, paternal age, and
paternal psychopathology, it was 3.34
(95% CI: 2.02–5.52). For the second
highest decile (80%–89%), the
association in the unadjusted analysis
revealed an OR of 2.71 (95% CI:
1.70–4.31) and in the adjusted
analyses, an OR of 1.91 (95% CI:
1.15–3.18; Table 3). The difference
between the deciles (80%–89% vs
90%–100%) was signiﬁcant, revealing
that the risk of ADHD was higher with
a higher level of nicotine exposure.
DISCUSSION
With this study, we provide evidence
for the association between nicotine
exposure during pregnancy and
increased risk of ADHD in the
offspring because previous
population-based studies have been
based on self-report of smoking
during pregnancy. The association
between fetal exposure to nicotine,
quantiﬁed as cotinine during
gestation, and ADHD were similar
when cotinine was classiﬁed as
a continuous variable and when it
was classiﬁed in 3 categories on the
basis of cotinine levels. Most
importantly, the ﬁndings reveal
a dose-dependent relationship
between fetal exposure to nicotine
and risk of ADHD. The ﬁndings
persisted in all analyses after
adjusting for potential confounders,
including maternal SES, maternal and
paternal psychopathology, maternal
and paternal age, and BWGA. To the
best of our knowledge, this is the ﬁrst
biomarker-based study to reveal
a relationship between fetal nicotine
exposure and later offspring ADHD.
The ﬁndings add to the evidence of
a complex association between
TABLE 2 Maternal Serum Cotinine Levels by Deciles in Patients With ADHD and Matched Controls
Maternal Cotinine by Deciles,a % Range, ng/mL Patients
(n = 1079)
Controls
(n = 1079)
n % n %
,10 ,0.008 67 6.2 107 9.9
10–19 0.009–0.011 73 6.8 108 10.0
20–29 0.012–0.014 66 6.1 107 9.9
30–39 0.015–0.019 89 8.2 109 10.1
40–49 0.020–0.024 96 8.9 112 10.4
50–59 0.025–0.033 99 9.2 104 9.6
60–69 0.034–0.052 88 8.2 108 10.0
70–79 0.053–0.165 118 10.9 108 10.0
80–89 0.166–41.08 139 12.9 108 10.0
$90 $41.08 244 22.6 108 10.0
a The cut points for deciles are based on maternal cotinine levels in the control group.
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exposure to nicotine during
pregnancy and later ADHD. A
neurobiological mechanism via
intrauterine effects seems possible
because nicotine crosses the placenta
during pregnancy.30 Animal studies
have demonstrated an association
between in utero nicotine exposure
and increased locomotor activity as
well as changes in the
neurotransmitter systems in the
brain.31,32 Human studies have
revealed structural and functional
changes in the brain associated with
prenatal smoking exposure.33 The
mechanisms behind these effects are
thought to develop through nicotine
modulating the maturation of the
developing central nervous system. In
addition, other components of
smoking, such as carbon monoxide,
are thought to lead to fetal hypoxia
and affect fetal brain development.34
The association between smoking
during pregnancy and offspring
ADHD may be explained by genetic or
social factors.9,35 On the basis of
several sibling and family studies, the
association between fetal exposure to
smoking and ADHD has been
suggested to be mostly explained by
familial confounding.8–13 These
studies, as well as a novel study
design on children born with assisted
conception,36 suggest that inherited
effects and unmeasured household-
level confounding seem more likely
contributors behind the association
than direct intrauterine effects of
smoking. There are also contradictory
sibling-study ﬁndings, including
results from a Finnish study with
.150000 sibling pairs, revealing that
if the mother stopped smoking
between the pregnancies, the second
sibling did not have an increased risk
of externalizing diagnoses, including
ADHD. Correspondingly, if the mother
started smoking between the
pregnancies, a signiﬁcantly higher
risk was observed in the second
sibling.37 A Dutch family study found
that maternal compared with
paternal smoking during pregnancy
was associated with a greater effect,
with externalizing problems among
offspring. The same study revealed
FIGURE 2
ORs and 95% CIs for maternal serum cotinine (deciles) and offspring ADHD.
TABLE 3 Association Between Maternal Serum Cotinine Categorized Into Deciles and Offspring ADHD
Maternal Cotinine by Deciles, % OR 95% CI P ORa 95% CI P
,10 Reference — — — Reference —
10–19 1.15 0.71–1.85 .56 1.18 0.71–1.96 .53
20–29 1.19 0.72–1.95 .50 1.07 0.63–1.83 .81
30–39 1.58 0.97–2.58 .07 1.67 0.98–2.84 .06
40–49 1.79 1.09–2.93 .02 1.60 0.94–2.72 .09
50–59 2.09 1.27–3.44 .004 2.01 1.18–3.44 .01
60–69 1.92 1.15–3.2 .013 1.71 0.98–2.98 .06
70–79 2.78 1.66–4.68 ,.001 2.38 1.35–4.21 .003
80–89 2.71 1.70–4.31 ,.001 1.91 1.15–3.18 .01
$90 4.90 3.10–7.76 ,.001 3.34 2.02–5.53 ,.001
—, not applicable.
a Adjusted for BWGA, maternal SES, maternal age, maternal psychopathology, maternal substance abuse, paternal age, and paternal psychopathology.
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that quitting smoking was associated
with less externalizing problems
among offspring.38 Furthermore, an
American sibling study revealed that
familial confounding explained
inattentive but not hyperactive and/
or impulsive ADHD behaviors,
suggesting that the association may
vary by phenotype.39
Despite several strengths, sibling
comparison studies should also be
interpreted with caution given their
limitations. It has been suggested that
within-sibling estimates will be biased
toward the null by measurement error
and that they may be either more or
less biased than between-family
estimates depending on the extent to
which siblings share confounders
versus the exposure.40 In addition,
mothers who vary in their smoking
habits during different pregnancies
can perhaps not be generalized to all
smoking populations.40
It is possible that the association
between nicotine exposure during
pregnancy and ADHD might partially
be explained also by gene-
environment interaction.
Accumulating data provide evidence
that prenatal smoking may act
through epigenetic changes via
altered DNA methylation and
microRNA expression.41,42 The
exposure to nicotine may increase the
risk of ADHD particularly among
children with genetic vulnerability for
ADHD. It is also possible that
maternal smoking during pregnancy
is a proxy risk factor leading to
ADHD by independent mechanisms.
Smoking during pregnancy is
associated with poorer parenting
skills, which are associated with child
behavioral problems.43
The current study has several
strengths, including being based on
a large nationwide sample, assessing
nicotine exposure with objective
biological measurement and
including several potential
confounders. However, when
interpreting the ﬁndings, several
limitations should be considered.
A key question is whether smoking
during pregnancy is causally
associated with ADHD or is a proxy of
another risk factor (eg, familial
confounding). Even if most of the
effect is due to familial or genetic
confounding, the current study
reveals that the association between
smoking and ADHD has a dose-
response effect. The limitation of
observational data is that we cannot
examine causal processes. We did not
have access to biomarkers of sibling
pregnancies that would have shed
more light on a possible causal link
between nicotine exposure during
pregnancy and offspring ADHD.
However, in the current study, we
were able to adjust for several
confounders, including BWGA,
maternal SES, age, psychopathology,
and substance use disorder as well as
paternal psychopathology. Information
about possible substance use during
pregnancy was restricted to register-
based substance use diagnoses. In the
current study, 5.3% of mothers of
children with ADHD had a diagnosis of
substance use disorder, which was
similar to the estimated prevalence in
Finland of 6.4% for the exposure to
maternal alcohol and drug
dependence.44 The number of parents
diagnosed with ADHD in this sample
was low, which is a limitation of the
study (Supplemental Tables 5 and 6).
The underdiagnoses among parents
could be primarily because ADHD was
not a widely used diagnosis in the
parental generation. In addition, it is
unlikely that ADHD among parents
was treated in inpatient care. Because
the FHDR did not cover outpatient
diagnoses before 1998, the diagnosis
of ADHD among parents is likely
underestimated. Finally, the subjects
with ADHD included in this study
were only those who were referred to
specialized services and likely
represent the more severe cases of
ADHD. However, authors of a previous
study reported an 88% validity of the
ADHD diagnoses in the FHDR
examined against Diagnostic and
Statistical Manual of Mental Disorders,
Fourth Edition criteria for ADHD.7
CONCLUSIONS
According to the World Health
Organization, smoking is considered 1
of the main public health concerns
worldwide.45 The current study
reveals a strong association between
prenatal nicotine exposure and
a dose-dependent relationship with
offspring ADHD. This study adds 2
important aspects; ﬁrst, the use of
cotinine as a documented measure of
nicotine exposure during pregnancy
and second, the ﬁnding of a dose-
response effect in the association.
Given the high prevalence of both
smoking during pregnancy and ADHD
among children, these ﬁndings
warrant future studies on the
interplay between maternal smoking
and environmental, genetic, and
epigenetic factors.
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